NCT01268774View on ClinicalTrials.gov

Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

CompletedOBSERVATIONAL
Enrollment

529

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions
Multiple Myeloma
Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY